Amedeo's Top 20

Amedeo Smart

Independent Medical Education

22 August 2022

Multidisciplinary Journal Club

  1. LeBoff MS, Chou SH, Ratliff KA, Cook NR, et al.
    Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults.
    N Engl J Med 2022;387:299-309.

  1. Onali S, Pugliese D, Caprioli FA, Orlando A, et al.
    An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors.
    Am J Gastroenterol 2022;117:1279-1287.

  2. Grebely J, Dore GJ, Altice FL, Conway B, et al.
    Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.
    Ann Intern Med 2022.

  3. Westin J, Davis RE, Feng L, Hagemeister F, et al.
    Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.
    J Clin Oncol 2022.

  4. Larsen D, Singh S, Brito M.
    Thyroid, Diet, and Alternative Approaches.
    J Clin Endocrinol Metab 2022.

  1. Morschhauser F, Nastoupil L, Feugier P, Schiano de Colella JM, et al.
    Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R(2)) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma.
    J Clin Oncol 2022.

  2. Miyauchi E, Morita S, Nakamura A, Hosomi Y, et al.
    Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR.
    J Clin Oncol 2022.

  3. Arroyo N, Bell KJL, Hsiao V, Fernandes-Taylor S, et al.
    Prevalence of Subclinical Papillary Thyroid Cancer by Age: Meta-analysis of Autopsy Studies.
    J Clin Endocrinol Metab 2022.

  4. Lassman AB, Hoang-Xuan K, Polley MC, Brandes AA, et al.
    Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.
    J Clin Oncol 2022;40:2539-2545.

  5. Mila-Aloma M, Ashton NJ, Shekari M, Salvado G, et al.
    Plasma p-tau231 and p-tau217 as state markers of amyloid-beta pathology in preclinical Alzheimer's disease.
    Nat Med 2022.

  1. Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, et al.
    Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.
    J Clin Oncol 2022;40:2546-2556.

  2. Vinogradov S, Hamid AA, Redish AD.
    Etiopathogenic Models of Psychosis Spectrum Illnesses Must Resolve Four Key Features.
    Biol Psychiatry 2022.

  3. Chua BH, Link EK, Kunkler IH, Whelan TJ, et al.
    Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
    Lancet 2022;400:431-440.

  4. Mohindra NA, Patel JD.
    Top advances in lung cancer, 2021.
    Cancer 2022.

  5. Cullaro G, Verna EC, McCulloch CE, Lai JC, et al.
    Improving the Model for End-Stage Liver Disease with sodium by incorporating kidney dysfunction types.
    Hepatology 2022;76:689-699.

  1. Schaff LR, Kushnirsky M, Lin AL, Nandakumar S, et al.
    Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case Series.
    Neurology 2022.

  2. Agrawal M, Christensen HS, Bogsted M, Colombel JF, et al.
    The rising burden of inflammatory bowel disease in Denmark over two decades: a nationwide cohort study.
    Gastroenterology 2022.

  3. Ma TM, Chu FI, Sandler H, Feng FY, et al.
    Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).
    Eur Urol 2022.

  4. Whelton PK, Carey RM, Mancia G, Kreutz R, et al.
    Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations.
    Circulation 2022.

  5. Lambertini M, Fielding S, Loibl S, Janni W, et al.
    Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy.
    J Natl Cancer Inst 2022;114:1117-1126.


more..

Privacy Policy